• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

AKT1通过诱导BRCA1和RAD51在细胞质中滞留来抑制同源重组。

AKT1 inhibits homologous recombination by inducing cytoplasmic retention of BRCA1 and RAD51.

作者信息

Plo Isabelle, Laulier Corentin, Gauthier Laurent, Lebrun Fabienne, Calvo Fabien, Lopez Bernard S

机构信息

Unité Mixte de Recherche Commissariat à l'Energie Atomique (CEA)-Centre National de la Recherche Scientifique (CNRS) 217, Fontenay aux Roses, 92265, France.

出版信息

Cancer Res. 2008 Nov 15;68(22):9404-12. doi: 10.1158/0008-5472.CAN-08-0861.

DOI:10.1158/0008-5472.CAN-08-0861
PMID:19010915
Abstract

AKT1 is frequently up-regulated in sporadic breast cancer, whereas BRCA1 is frequently mutated in familial breast cancer. Because BRCA1 is involved in homologous recombination (HR), we addressed whether AKT1 also has an effect on this process. We showed that AKT1 repressed HR through cytoplasmic retention of BRCA1 and RAD51 proteins, resulting in a BRCA1-deficient-like phenotype. This process does not require direct BRCA1 phosphorylation by AKT1. The cytoplasmic retention of BRCA1 and RAD51 correlated with activated AKT1 in tumor cell lines and in biopsies from sporadic breast cancers. Under nonpathologic conditions, fibroblast growth factor, which activates AKT1 and stimulates proliferation in fibroblasts, impaired excessive HR without fully inhibiting it, promoting genome stability. Our study reveals that the regulation of BRCA1 and RAD51 is altered in a high frequency of sporadic breast cancers and highlights the role of extracellular AKT signaling-dependent regulation of HR and genome stability.

摘要

AKT1在散发性乳腺癌中经常上调,而BRCA1在家族性乳腺癌中经常发生突变。由于BRCA1参与同源重组(HR),我们研究了AKT1是否也对这一过程有影响。我们发现AKT1通过将BRCA1和RAD51蛋白滞留在细胞质中来抑制HR,从而导致类似BRCA1缺陷的表型。这一过程并不需要AKT1直接对BRCA1进行磷酸化。BRCA1和RAD51的细胞质滞留与肿瘤细胞系以及散发性乳腺癌活检组织中激活的AKT1相关。在非病理条件下,激活AKT1并刺激成纤维细胞增殖的成纤维细胞生长因子会削弱过度的HR,但不会完全抑制它,从而促进基因组稳定性。我们的研究表明,在高比例的散发性乳腺癌中,BRCA1和RAD51的调控发生改变,并突出了细胞外AKT信号依赖的HR和基因组稳定性调控作用。

相似文献

1
AKT1 inhibits homologous recombination by inducing cytoplasmic retention of BRCA1 and RAD51.AKT1通过诱导BRCA1和RAD51在细胞质中滞留来抑制同源重组。
Cancer Res. 2008 Nov 15;68(22):9404-12. doi: 10.1158/0008-5472.CAN-08-0861.
2
AKT1 represses gene conversion induced by different genotoxic stresses and induces supernumerary centrosomes and aneuploidy in hamster ovary cells.AKT1抑制不同基因毒性应激诱导的基因转换,并在仓鼠卵巢细胞中诱导超数中心体和非整倍体。
Oncogene. 2009 Jun 4;28(22):2231-7. doi: 10.1038/onc.2009.85. Epub 2009 Apr 27.
3
BRCA1 regulates RAD51 function in response to DNA damage and suppresses spontaneous sister chromatid replication slippage: implications for sister chromatid cohesion, genome stability, and carcinogenesis.BRCA1在DNA损伤应答中调节RAD51功能,并抑制自发的姐妹染色单体复制滑移:对姐妹染色单体黏连、基因组稳定性和致癌作用的影响。
Cancer Res. 2005 Dec 15;65(24):11384-91. doi: 10.1158/0008-5472.CAN-05-2156.
4
Akt1 inhibits homologous recombination in Brca1-deficient cells by blocking the Chk1-Rad51 pathway.Akt1 通过阻断 Chk1-Rad51 通路抑制 Brca1 缺陷细胞中的同源重组。
Oncogene. 2013 Apr 11;32(15):1943-9. doi: 10.1038/onc.2012.211. Epub 2012 Jun 4.
5
AKT1/BRCA1 in the control of homologous recombination and genetic stability: the missing link between hereditary and sporadic breast cancers.AKT1/BRCA1对同源重组和遗传稳定性的调控:遗传性和散发性乳腺癌之间缺失的环节
Oncotarget. 2010 Dec;1(8):691-699. doi: 10.18632/oncotarget.203.
6
Homologous Recombination Repair Factors Rad51 and BRCA1 Are Necessary for Productive Replication of Human Papillomavirus 31.同源重组修复因子Rad51和BRCA1是人类乳头瘤病毒31有效复制所必需的。
J Virol. 2015 Dec 23;90(5):2639-52. doi: 10.1128/JVI.02495-15.
7
Bcl-2 inhibits nuclear homologous recombination by localizing BRCA1 to the endomembranes.Bcl-2 通过将 BRCA1 定位在内质网上来抑制核同源重组。
Cancer Res. 2011 May 15;71(10):3590-602. doi: 10.1158/0008-5472.CAN-10-3119. Epub 2011 Mar 28.
8
The carboxyl-terminal of BRCA1 is required for subnuclear assembly of RAD51 after treatment with cisplatin but not ionizing radiation in human breast and ovarian cancer cells.在人乳腺癌和卵巢癌细胞中,顺铂处理后,BRCA1的羧基末端是RAD51亚核组装所必需的,但电离辐射处理后并非如此。
Biochem Biophys Res Commun. 2005 Oct 28;336(3):952-60. doi: 10.1016/j.bbrc.2005.08.197.
9
Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.与肿瘤相关脂肪酸合酶依赖性乳腺癌细胞增殖和存活相关的新型信号分子:外源性膳食脂肪酸、p53-p21WAF1/CIP1、ERK1/2 MAPK、p27KIP1、BRCA1和NF-κB的作用
Int J Oncol. 2004 Mar;24(3):591-608.
10
Homologous recombination and human health: the roles of BRCA1, BRCA2, and associated proteins.同源重组与人类健康:BRCA1、BRCA2及相关蛋白的作用
Cold Spring Harb Perspect Biol. 2015 Apr 1;7(4):a016600. doi: 10.1101/cshperspect.a016600.

引用本文的文献

1
Genome rearrangements induced by the stimulation of end-joining of DNA double strand breaks through multiple phosphorylation of MRE11 by the kinase PKB/AKT1.激酶PKB/AKT1通过对MRE11进行多次磷酸化作用来刺激DNA双链断裂的末端连接,从而诱导基因组重排。
Nucleic Acids Res. 2025 Jun 6;53(11). doi: 10.1093/nar/gkaf468.
2
Isolation of Proteins on Chromatin Reveals Signaling Pathway-Dependent Alterations in the DNA-Bound Proteome.染色质上蛋白质的分离揭示了DNA结合蛋白质组中依赖信号通路的变化。
Mol Cell Proteomics. 2025 Mar;24(3):100908. doi: 10.1016/j.mcpro.2025.100908. Epub 2025 Jan 20.
3
S6K1 Controls DNA Damage Signaling Modulated by the MRN Complex to Induce Radioresistance in Lung Cancer.
S6K1 通过调控 MRN 复合物控制 DNA 损伤信号转导,从而诱导肺癌的放射抵抗。
Int J Mol Sci. 2024 Sep 28;25(19):10461. doi: 10.3390/ijms251910461.
4
Reversal of pulmonary veno-occlusive disease phenotypes by inhibition of the integrated stress response.抑制综合应激反应可逆转肺静脉闭塞病表型。
Nat Cardiovasc Res. 2024 Jul;3(7):799-818. doi: 10.1038/s44161-024-00495-z. Epub 2024 Jul 9.
5
RNA helicase DDX3 regulates RAD51 localization and DNA damage repair in Ewing sarcoma.RNA解旋酶DDX3调节尤因肉瘤中RAD51的定位和DNA损伤修复。
iScience. 2024 Jan 16;27(2):108925. doi: 10.1016/j.isci.2024.108925. eCollection 2024 Feb 16.
6
Methylation of NRIP3 Is a Synthetic Lethal Marker for Combined PI3K and ATR/ATM Inhibitors in Colorectal Cancer.NRIP3 的甲基化是结PI3K 和 ATR/ATM 抑制剂在结直肠癌中的合成致死标志物。
Clin Transl Gastroenterol. 2024 Mar 1;15(3):e00682. doi: 10.14309/ctg.0000000000000682.
7
Differential impact of cytoplasmic vs. nuclear RAD51 expression on breast cancer progression and patient prognosis.细胞质与核 RAD51 表达对乳腺癌进展和患者预后的差异影响。
Int J Oncol. 2024 Feb;64(2). doi: 10.3892/ijo.2023.5600. Epub 2023 Dec 8.
8
PTEN-mediated dephosphorylation of 53BP1 confers cellular resistance to DNA damage in cancer cells.PTEN 通过去磷酸化 53BP1 赋予癌细胞对 DNA 损伤的细胞抗性。
Mol Oncol. 2024 Mar;18(3):580-605. doi: 10.1002/1878-0261.13563. Epub 2023 Dec 12.
9
MAGI1 Prevents Senescence and Promotes the DNA Damage Response in ER Breast Cancer.MAGI1 可防止 ER 乳腺癌衰老并促进 DNA 损伤反应。
Cells. 2023 Jul 25;12(15):1929. doi: 10.3390/cells12151929.
10
Cervical cancer benefits from trabectedin combination with the β-blocker propranolol: and evaluations in patient-derived organoids.曲贝替定联合β受体阻滞剂普萘洛尔对宫颈癌有益:以及在患者来源的类器官中的评估。
Front Cell Dev Biol. 2023 Jun 13;11:1178316. doi: 10.3389/fcell.2023.1178316. eCollection 2023.